Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma

Cancer Research

Volumn 61, Issue 15, 2001, Pages 5911-5918

  Dong, G ^a   Chen, Z ^a   Li, Z Y ^a   Yeh, N T ^a   Bancroft, C C ^a   Van Waes, C ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; SCATTER FACTOR; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVATION; HEAD CANCER; HOST CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; NECK CANCER; ONCOGENE; PARACRINE SIGNALING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CARCINOMA, SQUAMOUS CELL; ENDOTHELIAL GROWTH FACTORS; ENZYME ACTIVATION; HEAD AND NECK NEOPLASMS; HEPATOCYTE GROWTH FACTOR; HUMANS; INTERLEUKIN-8; KERATINOCYTES; LYMPHOKINES; MAP KINASE KINASE KINASE 1; MAP KINASE SIGNALING SYSTEM; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-MET; RNA, MESSENGER; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035421326     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis
2. Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor
3. Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and u-PA receptor expression in Madin-Darby canine kidney epithelial cells
4. Hepatocyte growth factor (HGF) receptor expression is inducible and is part of the delayed-early response to HGF
5. Mechanisms of hepatocytes growth factor stimulation of keratinocyte metalloproteinase production
6. The ETS1 transcription factor is expressed during epithelial-mesenchymal transitions in the chick embryo and is activated in scatter factor-stimulated MDCK epithelial cells
7. Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas
8. Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer
9. Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer
10. Expression of c-met is a strong independent prognostic factor in breast carcinoma
11. Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas
12. Expression of c-Met in laryngeal carcinoma
13. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth
14. Scatter factor induces blood vessel formation in vivo
15. HGF/SF in angiogenesis
16. Regulation of angiogenesis by scatter factor
17. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo
18. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice
19. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility
20. Smooth muscle releases an epithelial cell scatter factor which binds to heparin
21. Expression of proinflammatory and proangiogenic cytokines in human head and neck patients
22. Effects of IL-1 α, IL-1RA, and neutralizing antibody on proinflammatory cytokine expression by human squamous cell carcinoma lines
23. The host environment promotes the development of primary and metastatic squamous cell carcinomas that constitutively express proinflammatory cytokines IL-1a, IL-6, GM-CSF and KC
24. Constitutive activation of a C-X-C chemokine KC promotes metastatic potential in murine squamous cell carcinoma
25. Serum levels of cytokines in patients with colorectal cancer: Possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis
26. Serum interleukin-8 (IL-8) is elevated in patients with metastatic melanoma and correlates with tumor load
27. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor
28. Inhibition of IL-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice
29. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice
30. Regulation of the expression of the VEGF/VPS and its receptors: Role in tumor angiogenesis
31. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: Concentration in tumor blood vessels
32. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo
33. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis
34. High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer
35. Vascular endothelial growth factor expression in head and neck squamous cell carcinoma
36. Hypoxia-induced elevation in interleukin-8 expression by human ovarian carcinoma cells
37. Human squamous cell carcinoma. Establishment and characterization of new permanent cell lines
38. Growth-inhibitory effects of epidermal growth factor and overexpression of its receptors on human squamous cell carcinomas in culture
39. Neoplastic transformation of human epidermal keratinocytes by AD12-SV40 and Kirsten sarcoma viruses
40. Control of I κB-α proteolysis by site-specific, signal-induced phosphorylation
41. Down-regulation of vascular endothelial growth factor in a human colon carcinoma cell line transfected with ah antisense expression vector specific for c-src
42. Hepatocyte growth factor/scatter factor and its receptor c-Met are overexpressed and associated with an increased microvessel density in malignant pleural mesothelioma
43. Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis
44. Cyclooxygenase regulates human oropharyngel carcinoma via the pro-inflammatory cytokine IL-6: A general role for inflammation?
45. Hepatocyte growth factor/scatter factor (HGF/SF) induces vascular permeability factor (VPF/VEGF) expression by cultured keratinocytes
46. Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells
47. IL-1α promotes NF-κB and AP-1 induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinoma
48. Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product
49. Tyrosine 1356 in the carboxyl-terminal tail of the HGF/SF receptor is essential for the transduction of signals for cell motility and morphogenesis
50. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family
51. Efficient cell transformation by the Tpr-Met oncoprotein is dependent upon tyrosine 489 in the carboxy-terminus
52. Specific uncoupling of GRB2 from the Met receptor. Differential effects on transformation and motility
53. Branching tubulogenesis but not scatter of Madin-Darby canine kidney cells requires a functional Grb2 binding site in the Met receptor tyrosine kinase
54. Differential requirement of Grb2 and PI3-kinase in HGF/SF-induced cell motility and tubulogenesis
55. Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis
56. Differential signaling by alternative HGF isoforms through c-Met: Activation of both MAP kinase and PI 3-kinase pathways is insufficient for mitogenesis
57. Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated monocytes
58. Activation of ERK2 by respiratory, syncytial virus in A549 cells is linked to the production of interleukin 8
59. p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts
60. Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-I transcriptional element